Trademark: 97169063
Status Date
Monday, January 8, 2024
Filing Date
Monday, December 13, 2021
Published for Opposition
Tuesday, April 11, 2023
Abandoned Date
Monday, January 8, 2024
5 Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases
Jan 8, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 8, 2024
Abandonment - No Use Statement Filed
Jun 6, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2023
Published For Opposition
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Mar 7, 2023
Approved For Pub - Principal Register
Mar 7, 2023
Examiner's Amendment Entered
Mar 7, 2023
Notification Of Examiners Amendment E-Mailed
Mar 7, 2023
Examiners Amendment E-Mailed
Mar 7, 2023
Examiners Amendment -Written
Sep 21, 2022
Notification Of Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action Written
Sep 20, 2022
Assigned To Examiner
Dec 16, 2021
New Application Office Supplied Data Entered
Dec 16, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24